Insider · CIK 0001969082
Jeff Cislini
Files at RVMD (Revolution Medicines, Inc.). First filing Nov 20, 2023, latest Sep 29, 2026.
In brief
Jeff Cislini files SEC Form 4 as officer at RVMD (Revolution Medicines, Inc.). Since Nov 20, 2023, Jeff Cislini has reported 0 open-market buys worth $0 and 25 open-market sells worth $17M, the latest filed on Sep 29, 2026.
A track record needs three past buys with six months of prices behind them; Jeff Cislini has 0, so none is measured yet.
The newest scored trade: sold $159k of RVMD on Sep 25, 2026, filed Sep 29, 2026, scored 21 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 9 sells worth $15M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RVMD: Revolution Medicines, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | Revolution Medicines, Inc. | $159k 765 shares | -1% | +382% from low-7% from high | |
| 30Weak | Revolution Medicines, Inc. | $671k 3,366 shares | -6% | +361% from low-11% from high | |
| 40Moderate | Revolution Medicines, Inc. | $12M 56,894 shares | -50% | +487% from low-3% from high | |
| 25Weak | Revolution Medicines, Inc. | $337k 2,157 shares | -4% | +351% from low-4% from high | |
| 24Weak | Revolution Medicines, Inc. | $292k 2,958 shares | -5% | +218% from low-20% from high | |
| 20Weak | Revolution Medicines, Inc. | $105k 908 shares | -2% | +278% from low-5% from high | |
| 22Weak | Revolution Medicines, Inc. | $206k 2,688 shares | -5% | +149% from low-3% from high | |
| 24Weak | Revolution Medicines, Inc. | $939k 13,388 shares | -21% | +127% from low0% from high | |
| 20Weak | Revolution Medicines, Inc. | $660k 12,000 shares | -19% | +74% from low-11% from high | |
| 19Weak | Revolution Medicines, Inc. | $80k 1,799 shares | -3% | +40% from low-28% from high | |
| 19Weak | Revolution Medicines, Inc. | $86k 1,869 shares | -3% | +44% from low-26% from high | |
| 18Weak | Revolution Medicines, Inc. | $76k 1,912 shares | -3% | +27% from low-35% from high | |
| 18Weak | Revolution Medicines, Inc. | $75k 1,878 shares | -3% | +28% from low-34% from high | |
| 19Weak | Revolution Medicines, Inc. | $79k 2,041 shares | -3% | +5% from low-36% from high | |
| 17Weak | Revolution Medicines, Inc. | $57k 1,458 shares | -2% | +6% from low-35% from high | |
| 5Weak | Revolution Medicines, Inc. | $97k 2,406 shares | -6% | +1% from low-34% from high | |
| 18Weak | Revolution Medicines, Inc. | $73k 1,599 shares | -4% | - | |
| 21Weak | Revolution Medicines, Inc. | $141k 2,554 shares | -6% | - | |
| 15Weak | Revolution Medicines, Inc. | $360k 6,000 shares | -12% | - | |
| 14Weak | Revolution Medicines, Inc. | $301k 6,000 shares | -12% | - | |
| 9Weak | Revolution Medicines, Inc. | $46k 1,500 shares | -3% | +73% from low-10% from high | |
| 9Weak | Revolution Medicines, Inc. | $40k 1,252 shares | -2% | +69% from low-12% from high | |
| 1Weak | Revolution Medicines, Inc. | $41k 1,500 shares | -4% | +50% from low-21% from high | |
| 15Weak | Revolution Medicines, Inc. | $32k 1,229 shares | -3% | +43% from low-25% from high | |
| 1Weak | Revolution Medicines, Inc. | $33k 1,500 shares | -4% | +18% from low-38% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 15, 2026 | RVMD Revolution Medicines, Inc. | 3,272 0.00% of outstanding | $667k | Sep 15, 2026 | $12M |
| Aug 21, 2026 | RVMD REVOLUTION MEDICINES INC | 75,894 0.04% of outstanding | $16M | Aug 21, 2026 | $337k |
| Jun 15, 2026 | RVMD Revolution Medicines, Inc. | 1,656 0.00% of outstanding | $255k | Jun 15, 2026 | $292k |
| Mar 19, 2026 | RVMD REVOLUTION MEDICINES, INC. | 1,163 0.00% of outstanding | $114k | Mar 19, 2026 | $309k |
| Mar 13, 2026 | RVMD Revolution Medicines, Inc. | 2,053 0.00% of outstanding | $204k | Mar 16, 2026 | $311k |
| Jan 21, 2026 | RVMD REVOLUTION MEDICINES INC | 908 0.00% of outstanding | $106k | Jan 21, 2026 | $1.1M |
| Dec 12, 2025 | RVMD Revolution Medicines, Inc. | 2,614 0.00% of outstanding | $203k | Dec 15, 2025 | $1.8M |
| Nov 18, 2025 | RVMD REVOLUTION MEDICINES INC | 13,388 0.01% of outstanding | $926k | Nov 18, 2025 | $825k |
| Oct 17, 2025 | RVMD REVOLUTION MEDICINES INC | 12,000 0.01% of outstanding | $596k | Oct 17, 2025 | $165k |
| Sep 24, 2025 | RVMD REVOLUTION MEDICINES INC | 1,799 0.00% of outstanding | $80k | Sep 24, 2025 | $86k |
| Sep 15, 2025 | RVMD Revolution Medicines, Inc. | 1,842 0.00% of outstanding | $86k | Sep 15, 2025 | $151k |
| Jun 20, 2025 | RVMD REVOLUTION MEDICINES, INC. | 1,912 0.00% of outstanding | $76k | Jun 20, 2025 | $75k |
| Jun 13, 2025 | RVMD Revolution Medicines, Inc. | 1,842 0.00% of outstanding | $75k | Jun 16, 2025 | $136k |
| Mar 20, 2025 | RVMD REVOLUTION MEDICINES, INC. | 2,041 0.00% of outstanding | $79k | Mar 20, 2025 | $154k |
| Mar 14, 2025 | RVMD Revolution Medicines, Inc. | 1,650 0.00% of outstanding | $64k | Mar 17, 2025 | $170k |
| Jan 21, 2025 | RVMD REVOLUTION MEDICINES INC | 2,406 0.00% of outstanding | $97k | Jan 21, 2025 | $501k |
| Dec 16, 2024 | RVMD Revolution Medicines, Inc. | 1,432 0.00% of outstanding | $64k | Dec 16, 2024 | $866k |
| Nov 15, 2024 | RVMD REVOLUTION MEDICINES INC | 2,554 0.00% of outstanding | $147k | Nov 15, 2024 | $661k |
| Nov 6, 2024 | RVMD REVOLUTION MEDICINES INC | 6,000 0.00% of outstanding | $341k | Nov 6, 2024 | $301k |
| Oct 11, 2024 | RVMD REVOLUTION MEDICINES INC | 6,000 0.00% of outstanding | $297k | Oct 11, 2024 | none |
| Mar 27, 2024 | RVMD REVOLUTION MEDICINES INC | 1,500 0.00% of outstanding | $45k | Mar 27, 2024 | $41k |
| Mar 15, 2024 | RVMD Revolution Medicines, Inc. | 1,414 0.00% of outstanding | $47k | Mar 15, 2024 | $72k |
| Jan 22, 2024 | RVMD REVOLUTION MEDICINES INC | 1,500 0.00% of outstanding | $40k | Jan 22, 2024 | $33k |
| Dec 14, 2023 | RVMD Revolution Medicines, Inc. | 1,193 0.00% of outstanding | $29k | Dec 18, 2023 | $127k |
| Nov 20, 2023 | RVMD REVOLUTION MEDICINES INC | 1,500 0.00% of outstanding | $32k | Nov 20, 2023 | $56k |
Transactions
The newest 50 of 51 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -765 | $207.32 | $159k | 51,776 | 14 d ago |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -52 | $195.01 | $10k | 55,855 | 25 d ago |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -3,314 | $199.30 | $660k | 52,541 | 25 d ago |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +29,680 | $18.56 | $551k | 86,201 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +26,600 | $21.61 | $575k | 112,801 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -3,400 | $207.24 | $705k | 109,401 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -17,323 | $208.37 | $3.6M | 92,078 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -25,817 | $209.25 | $5.4M | 66,261 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,540 | $210.26 | $534k | 63,721 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $211.34 | $951k | 59,221 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -3,314 | $212.06 | $703k | 55,907 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -29,680 | $0.00 | $0 | 0 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -26,600 | $0.00 | $0 | 3,500 | Aug 25, 2026 |
| Jun 16, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,157 | $156.12 | $337k | 56,521 | Jun 18, 2026 |
| Mar 17, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,795 | $99.48 | $179k | 59,681 | Mar 19, 2026 |
| Mar 19, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,163 | $97.44 | $113k | 58,518 | Mar 19, 2026 |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +14,500 | $0.00 | $0 | 61,476 | Mar 3, 2026 |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +32,500 | $0.00 | $0 | 32,500 | Mar 3, 2026 |
| Jan 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -908 | $115.60 | $105k | 46,976 | Jan 23, 2026 |
| Dec 16, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,688 | $76.82 | $206k | 47,884 | Dec 18, 2025 |
| Nov 18, 2025 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +13,388 | $42.45 | $568k | 63,813 | Nov 20, 2025 |
| Nov 18, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -13,388 | $70.14 | $939k | 50,425 | Nov 20, 2025 |
| Nov 18, 2025 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -13,388 | $0.00 | $0 | 0 | Nov 20, 2025 |
| Oct 17, 2025 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +12,000 | $36.57 | $439k | 62,425 | Oct 20, 2025 |
| Oct 17, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -12,000 | $55.00 | $660k | 50,425 | Oct 20, 2025 |
| Oct 17, 2025 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 18,000 | Oct 20, 2025 |
| Sep 24, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,799 | $44.26 | $80k | 50,425 | Sep 26, 2025 |
| Sep 16, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,869 | $45.82 | $86k | 52,224 | Sep 18, 2025 |
| Jun 20, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,912 | $39.61 | $76k | 54,093 | Jun 23, 2025 |
| Jun 16, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,878 | $39.83 | $75k | 56,005 | Jun 18, 2025 |
| Mar 20, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,041 | $38.71 | $79k | 57,723 | Mar 24, 2025 |
| Mar 17, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,458 | $39.04 | $57k | 59,764 | Mar 19, 2025 |
| Mar 1, 2025 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +22,000 | $0.00 | $0 | 61,222 | Mar 4, 2025 |
| Mar 1, 2025 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +77,000 | $0.00 | $0 | 77,000 | Mar 4, 2025 |
| Jan 21, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,406 | $40.50 | $97k | 39,222 | Jan 22, 2025 |
| Dec 16, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,599 | $45.40 | $73k | 41,628 | Dec 18, 2024 |
| Nov 15, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,554 | $55.13 | $141k | 43,080 | Nov 19, 2024 |
| Nov 6, 2024 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $36.57 | $219k | 51,634 | Nov 8, 2024 |
| Nov 6, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $60.00 | $360k | 45,634 | Nov 8, 2024 |
| Nov 6, 2024 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 30,000 | Nov 8, 2024 |
| Oct 11, 2024 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $36.57 | $219k | 51,634 | Oct 15, 2024 |
| Oct 11, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $50.17 | $301k | 45,634 | Oct 15, 2024 |
| Oct 11, 2024 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 36,000 | Oct 15, 2024 |
| Mar 27, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -700 | $30.38 | $21k | 55,174 | Mar 28, 2024 |
| Mar 27, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -800 | $31.52 | $25k | 54,374 | Mar 28, 2024 |
| Mar 18, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,252 | $31.58 | $40k | 55,874 | Mar 20, 2024 |
| Mar 1, 2024 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +21,000 | $0.00 | $0 | 57,126 | Mar 5, 2024 |
| Mar 1, 2024 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +73,500 | $0.00 | $0 | 73,500 | Mar 5, 2024 |
| Jan 22, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,500 | $27.00 | $41k | 36,126 | Jan 24, 2024 |
| Dec 18, 2023 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,229 | $25.90 | $32k | 37,284 | Dec 20, 2023 |
Questions about Jeff Cislini
Answered from the filings on this page, as of the latest one.
Is Jeff Cislini buying or selling?
In the last 12 months Jeff Cislini reported 0 open-market buys worth $0 and 9 open-market sells worth $15M on SEC Form 4; the latest was sold $159k of RVMD on Sep 25, 2026. Grants, option exercises and tax withholding are not counted.
How did Jeff Cislini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeff Cislini has 0.
Where does Jeff Cislini file Form 4?
Jeff Cislini has filed Form 4 at RVMD (Revolution Medicines, Inc.) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.